CV SCIENCES, INC. (OTCMKTS:CVSI) Files An 8-K Other EventsItem 8.01Other Events.
On August 22, 2018, CV Sciences, Inc. (the “Company”) issued a press release announcing that fully repaid the promissory note payable (“Promissory Note”) to Wiltshire, LLC in cash, thus avoiding any remaining interest payments due on the Promissory Note. The Company issued the Promissory Note on November 9, 2017 in the principal amount of $850,000, with an original due date of May 9, 2019.
A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.
Item 9.01Financial Statements and Exhibits.
| (d) | Exhibits |
|
99.1 |
Press Release of CV Sciences, Inc., dated August 22, 2018 |
CV Sciences, Inc. ExhibitEX-99.1 2 cv_ex9901.htm PRESS RELEASE Exhibit 99.1 CV SCIENCES,…To view the full exhibit click here
About CV SCIENCES, INC. (OTCMKTS:CVSI)
CV Sciences, Inc. is a life science company. The Company operates in two segments: specialty pharmaceuticals and consumer products. The Company’s specialty pharma business segment is focused on developing and commercializing therapeutics utilizing synthetic Cannabidiol (CBD) across several therapeutic areas. The consumer product business segment is focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors.
